Doctors are a key part of the medical community and should lead the decarbonisation of healthcare and advocate for sustainability, according to Dr Jesse Gale, chair of the Royal Australian and New Zealand College of Ophthalmology’s (RANZCO’s) sustainability committee. Sharing this view online at RAN
Following a successful pilot study and comprehensive consultation, the Optometrists and Dispensing Opticians Board (ODOB) has approved a new scope of practice allowing optometrists to perform ophthalmic laser surgery.
In a recent survey, Western doctors blamed burnout and staff shortages for an increase in medical errors, while half of respondents said they had considered leaving their profession in the past three months.
Coming together for the first time, O=Mega23, the largest clinical conference and trade show for optometry in the Southern Hemisphere, and the fourth World Congress of Optometry will firmly plant Australian optometry on the world stage next year, say organisers.
Twelve years in the making, Vision Bus Aotearoa was officially launched on 10 June at a University of Auckland ceremony attended by Governor-General Dame Cindy Kiro.
Innovative 3D-printed eyewear designer Monoqool has released a new screw-free Slider series, including model Double Agent featured here. These soft-looking frames are so flexible and lightweight you almost forget you’re wearing them, said founder Allan Petersen. Distributed by Phoenix Eyewear.
A research project proposing a novel non-invasive method to measure intracranial pressure (ICP), in a safe and timely manner, has been awarded one of 17 Explorer Grants by New Zealand’s Health Research Council (HRC).
Titled ‘A Secure Future’, the 2022 Budget included $191m over two years for Pharmac and $168m for the Māori Health Authority, as part of a record-breaking $13.2bn healthcare investment.
Ashvattha Therapeutics’ phase 1 trial of patient-administered subcutaneous doses of its anti-VEGF therapy have shown it to be safe and well tolerated in healthy subjects. “We are advancing this first-in-class therapy to enable patients the convenience of self-administration with an autoinjector up t
Australian researchers have found retinal pigment epithelial (RPE) cells appear to be particularly susceptible to harbouring Ebola and other viruses. Uveitis occurs in up to one-third of Ebola
Researchers from the National Eye Institute (NEI) have identified a novel genetic macular dystrophy, which is yet to be named. “Affected individuals had scotomas and changes in their maculas
Clinical trial results for Tepezza, the only thyroid eye disease (TED) treatment approved by the US Food and Drug Administration (FDA), have associated the drug with hyperglycaemia in 10% of